Literature DB >> 21643730

Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.

Jun Yang1, Stephen M Dombrowski, Abhishek Deshpande, Natalie Krajcir, Serge El-Khoury, Chandra Krishnan, Mark G Luciano.   

Abstract

Vascular endothelial growth factor (VEGF) is a promising biological marker and prognostic indicator in many neurological diseases. Although VEGF concentrations in plasma and cerebrospinal fluid (CSF) are increasingly reported, CSF-VEGF stability pre- and during-assay procedures is seldom evaluated. In the current study, we investigated VEGF variability and stability in CSF related to sample preparation, storage, and routine experimental procedures. Results showed that contaminant cell breakdown or aggregation can occur gradually before sample processing. However, after the removal of contaminant cell components, CSF-VEGF levels did not show significant changes in samples incubated at room temperature for 5 h, thawed/refrozen for 6 cycles. Samples preserved at -80 °C for up to 7 years continued to show measurable levels. Since some cellular components such as platelets contain a large amount of releasable VEGF, we conclude that CSF samples should be processed as soon as possible to carefully remove all cellular components and prevent possible consequent release of VEGF into CSF. After centrifugation to remove cellular contents, VEGF in CSF was relatively stable during routine experimental procedures and storage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643730     DOI: 10.1007/s11064-011-0517-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Vascular endothelial growth factor platelet counts, and prognosis in renal cancer.

Authors:  K J O'Byrne; N Dobbs; D Propper; K Smith; A L Harris
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

2.  Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood.

Authors:  E Gunsilius; A Petzer; G Stockhammer; W Nussbaumer; P Schumacher; J Clausen; G Gastl
Journal:  Oncology       Date:  2000-02       Impact factor: 2.935

3.  High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer.

Authors:  P Salven; T Ruotsalainen; K Mattson; H Joensuu
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

4.  Prolonged holding of whole blood at 22 degrees C does not increase activation in platelet concentrates.

Authors:  C Sanz; A Pereira; A I Faúndez; A Ordinas
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

5.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.

Authors:  R Möhle; D Green; M A Moore; R L Nachman; S Rafii
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients.

Authors:  J Javier Provencio; Pia Kivisäkk; Barbara H Tucky; Mark G Luciano; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2005-04-22       Impact factor: 3.478

7.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

8.  Vascular endothelial growth factor as prognostic factor in renal cell carcinoma.

Authors:  J Jacobsen; T Rasmuson; K Grankvist; B Ljungberg
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

9.  In vitro release of vascular endothelial growth factor during platelet aggregation.

Authors:  J P Maloney; C C Silliman; D R Ambruso; J Wang; R M Tuder; N F Voelkel
Journal:  Am J Physiol       Date:  1998-09

Review 10.  Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy.

Authors:  A L Harris
Journal:  Recent Results Cancer Res       Date:  1998
View more
  3 in total

Review 1.  Wound samples: moving towards a standardised method of collection and analysis.

Authors:  Sarah Ramsay; Linda Cowan; Jeffrey M Davidson; Lillian Nanney; Gregory Schultz
Journal:  Int Wound J       Date:  2015-01-11       Impact factor: 3.315

2.  Longitudinal Metabolite Profiling of Cerebrospinal Fluid in Normal Pressure Hydrocephalus Links Brain Metabolism with Exercise-Induced VEGF Production and Clinical Outcome.

Authors:  He Huang; Jun Yang; Mark Luciano; Leah P Shriver
Journal:  Neurochem Res       Date:  2016-04-15       Impact factor: 3.996

3.  A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor.

Authors:  Ulrika Sjöbom; Anders K Nilsson; Hanna Gyllensten; Ann Hellström; Chatarina Löfqvist
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.